IP Library Granted Patent US 7,256,299
Granted Patent B2
US 7,256,299 · App. 10/764,388 · Granted Aug 14, 2007

Chemiluminescent reagents

Assignee: Enzo Life Sciences, Inc. c/o Enzo Biochem, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,256,299
App. No.
10/764,388
Granted
Aug 14, 2007
Kind
B2
Abstract

This invention provides for labeling reagents, labeled targets and processes for preparing labeling reagents. The labeling reagents can take the form of cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes. These labeling reagents are useful for labeling probes or targets, including nucleic acids and proteins. These reagents can be usefully applied to protein and nucleic acid probe based assays. They are also applicable to real-time detection processes.

Claims (18)

1. A chemiluminescent reagent having the structure:

wherein Q comprises a cycloalkyl or polycycloalkyl group attached covalently to the 4-membered ring portion of said dioxetane above directly or indirectly through a linkage group; wherein Z comprises hydrogen, alkyl, aryl, aralkyl, alkaryl, heteroalkyl, heteroaryl, cycloalkyl or cycloheteroalkyl; and wherein R 1 and R 2 comprise chemical moieties attached to different sites of a cyclic ring attached to said dioxetane, and wherein R 1 is enzymatically converted into R 1 * which comprises a chemical reactive group G 1 , and wherein R 2 is attached to said cyclic ring through an oxygen atom and comprises a chemical reactive group G 2 which reacts with said G 1 to convert said dioxetane to an unstable light-emitting dioxetane form.

2. The chemiluminescent reagent of claim 1 , wherein said Q comprises an adamantyl group.

3. The chemiluminescent reagent of claim 1 , wherein said cyclic ring comprises an aromatic ring.

4. The chemiluminescent reagent of claim 1 , wherein R 2 comprises a substituted or unsubstituted aliphatic group or an unsubstituted aromatic group.

5. The chemiluminescent reagent of claim 4 , wherein said substituted aliphatic group comprises halogen or sulfonates.

6. The chemiluminescent reagent of claim 1 , wherein enzymatically convertible R 1 comprises glucose, xylose, fucose, amino acids or esters of phosphates, carboxylic acids or fatty acids.

7. The chemiluminescent reagent of claim 1 , wherein R 1 is enzymatically converted into R 1 * through the action of enzymes comprising an amidases, trypsin or chymotrypsin.

8. The chemiluminescent reagent of claim 1 , wherein after said enzymatic conversion of R 1 to R 1 * and before said conversion of said dioxetane to the unstable light-emitting dioxetane form, an intermediate five- or six-membered ring is formed comprising a linkage between said G 1 and G 2.

9. A chemiluminescent reagent having the structure:

wherein Q comprises a cycloalkyl or polycycloalkyl group attached covalently to the 4-membered ring portion of said dioxetane above directly or indirectly through a linkage group; wherein Z comprises hydrogen, alkyl, aryl, aralkyl, alkaryl, heteroalkyl, heteroaryl, cycloalkyl or cycloheteroalkyl; and wherein R comprises a chemical linker having a reactive site attached to the aromatic ring in said structure; and wherein R′ comprises a substrate for an non-cleaving enzymatic process, wherein the product of said enzymatic process leads to further chemical rearrangements that generate an unstable light emitting dioxetane form.

10. The chemiluminescent reagent of claim 9 , wherein said non-cleaving enzymatic process comprises oxidation or reduction.

11. The chemiluminescent reagent of claim 9 , wherein said Q comprises an adamantyl group.

12. The chemiluminescent reagent of claim 9 , wherein R comprises a substituted or unsubstituted aliphatic group or an unsubstituted aromatic group.

13. The chemiluminescent reagent of claim 12 , wherein said substituted aliphatic group comprises halogen, or sulfonate.

14. The chemiluminescent reagent of claim 9 , wherein said reactive site comprises an oxygen, a nitrogen or a sulfur atom.

15. The chemiluminescent reagent of claim 9 , wherein said enzymatic process is carried out by an enzyme comprising an oxidase or reductase.

16. The chemiluminescent reagent of claim 9 , wherein after said enzymatic process, said dioxetane is converted to an unstable light-emitting dioxetane form.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2015
From: STAVRIANOPOULOS, JANNIS G.; RABBANI, ELAZAR
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 036771/0058 →
Continuity (2)
Division 1009607500 · Mar 12, 2002
Related Publication 20050004350A1 · Jan 6, 2005